4//SEC Filing
Zarrabian Saiid 4
Accession 0000905718-20-000969
CIK 0001498382other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 9:07 PM ET
Size
5.6 KB
Accession
0000905718-20-000969
Insider Transaction Report
Form 4
Zarrabian Saiid
DirectorInterim CEO
Transactions
- Award
Options (Right to Buy)
2020-09-15+2,715,004→ 2,715,004 totalExercise: $1.70Exp: 2030-09-15→ Common Stock (2,715,004 underlying)
Footnotes (1)
- [F1]The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued employment, 1/6th of the options vest on March 15, 2021, with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 15, 2021.
Documents
Issuer
Kintara Therapeutics, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001495521
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 9:07 PM ET
- Size
- 5.6 KB